Infectious Disease and Immunology Risk Assessment: Recognition, Infection Control and Medication Safety

This assessment shows how an infection team can find, rate and control the risks that matter most to patient safety, staff health and trust in clinical care. Eight risks were chosen because they are plausible on a ward and in an infection clinic. Delayed recognition of sepsis carries the highest inherent score, because a missed warning can cause serious harm quickly. Infection spread, antimicrobial errors, specimen problems, staff exposure and handover gaps are rated High before controls. Most risks fall to Medium or Low once added controls are in place, and sepsis recognition stays Medium because harm is serious even when the chance is lower. The first actions are a sepsis screening prompt, isolation checks at every transfer and a pharmacy review date on every antimicrobial course. The service is a teaching example, so every score illustrates method, not a real organization or patient group.

Scope

This assessment covers adults with suspected or confirmed infections and immune-related conditions on an inpatient ward and in an outpatient infection clinic, from triage and diagnosis to treatment, isolation and discharge. It considers risks to patient safety, staff health, information and service continuity. It does not give clinical guidance for any patient or treatment. Jurisdiction, service size, laboratory arrangements and local policy are assumptions made for teaching and are listed below.

Context

The ward has a medical team, nursing staff, a pharmacist and an infection prevention team. A microbiology laboratory reports results through an electronic system, and the outpatient clinic manages biologic and immunosuppressive therapies with scheduled monitoring. Handover takes place at each shift change, and surge demand can occur during seasonal or outbreak pressure. Each risk is scored before controls to show its natural level, then again after the existing controls and the controls that should be added.

Objectives, assets and stakeholders

The objective is to recognize deterioration early, prevent infection spread, give safe and effective treatment, protect staff, and keep patient information private and accurate. The assets in scope are patients, the ward and clinic environment, medicines and laboratory samples, clinical records, monitoring equipment and the trust of patients and families. Stakeholders include patients and families, nurses, doctors, pharmacists, laboratory staff, the infection prevention team, occupational health, information governance staff and the service leadership. Clear roles matter: every risk has one owner role, and the clinical lead reports the register to the governance meeting each quarter.

Each risk is rated on two five-point scales. Likelihood runs from Rare to Almost certain, and impact runs from Insignificant to Catastrophic. Multiplying the two gives a score from 1 to 25, which falls into one of four bands: Low from 1 to 4, Medium from 5 to 9, High from 10 to 16 and Critical from 17 to 25. The score is a guide for ordering work, not a measurement of clinical risk for any patient. Inherent risk is the score before any controls. Residual risk is the score after existing and added controls. Impact is judged on physical harm, the need for extra treatment, effect on other patients and staff, and harm to trust. A Critical or High risk needs senior clinical attention and a dated plan, a Medium risk needs routine controls with a named owner, and a Low risk is accepted and watched. Clinicians who do the work should challenge every rating, and any score is reviewed when an indicator reaches its threshold. Clinical judgement always takes precedence over a score in an individual patient's care.

Contingency arrangements

If a serious event occurs, such as a suspected outbreak, a sepsis death or a medicines incident, the clinical lead activates the escalation route and informs the on-call senior clinician. The infection prevention lead applies isolation and cohorting while the outbreak is assessed. The pharmacist reviews all affected prescriptions, and the laboratory manager confirms results. The information governance lead secures records and advises on notifications. Staff and families are told what they need to know early and plainly, and the event is reported for learning.

Conclusion

Safe infection care depends on a few steady habits: early recognition, isolation checks at every transfer, review dates for every antimicrobial course, clear handovers and tested equipment. The highest scores sit with delayed sepsis recognition and infection spread, and each has actions that bring the residual score down. Treat the register as a living record, review it on the stated cycle, and seek qualified clinical and regulatory advice for any real patient decision.